Delivery Order SPE2DB22D2206-SPE2DB25FGW96

Award Date 5/8/25
Potential Completion Date 5/9/25
Potential Value $4.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,464.09, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a prime contractor and subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of 4,563,905,554 units of Methylphenidate ER (long-acting) 10mg capsules, with a completion date of March 11, 2024. The contract is a firm fixed-price Delivery Order with no set-aside designation. Amerisourcebergen Drug Corp also holds an Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,557,327 units of Methylphenidate ER (long-acting) 10mg capsules, with a total ceiling value of $1,188.90. The contract is a Firm Fixed Price Delivery Order, with a period of performance ending on March 12, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, a $1,899.80 delivery order, is for the supply of Methylphenidate ER (long-acting) 10mg capsules. The contract has an ultimate completion date of April 15, 2025 and utilizes a firm fixed price pricing type. This contract award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that...
This federal contract award, valued at $5,774.14, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,567,926,849 units of Methylphenidate ER 18 mg tablets. The contract is a Firm Fixed Price Delivery Order with a performance period extending through April 16, 2025. Amerisourcebergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a for-profit organization that serves as a critical supplier of...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a Delivery Order with a Firm Fixed Price valued at $1,163.01 and covers the supply of Methylphenidate ER (long-acting) 10mg capsules. The contract has an ultimate completion date of October 31, 2024. AmerisourceBergen is the prime contractor and holds two Indefinite Delivery Contracts (IDCs) with DLA and the Department of Justice Federal...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,428.07, is a delivery order to supply the government with 4567489416 - Methylphenidate ER (long-acting) 10mg capsules. The contract has a completion date of March 7, 2025 and uses a firm fixed price pricing type. It is not designated as a set-aside contract. AmerisourceBergen holds a significant...
This federal contract award is for the delivery of 4,562,020,694 units of Methylphenidate ER (long-acting) 10mg capsules, worth $1,965.94. The contract was awarded by the Defense Logistics Agency (DLA) to the prime contractor, AmerisourceBergen Drug Corp, on August 29, 2023, with an ultimate completion date of August 30, 2023. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of 4,567,553,294 units of Methylphenidate ER (Extended Release) 10mg capsules. The award, valued at $1,777.16, is a Firm Fixed Price Delivery Order and does not have a set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, is the prime contractor for this award. The contract has an ultimate completion...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,741.00, is for the delivery of 4,565,795,693 units of the medication Methylphenidate ER (long-acting) 10 mg capsules. The contract has a firm fixed price pricing type and does not have any set-aside designation, indicating open competition. The place of performance is Conshohocken, PA. AmerisourceBergen holds a...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 4,567,618,148 units of Methylphenidate ER 18 mg tablets. The $1,328.57 firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA), a defense agency. The contract has a period of performance through March 19, 2025 and was not set aside for any specific business type. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with DLA...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB25FGW96
    Delivery Order

This federal contract award, valued at $4,155.37, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of 4,568,189,117 units of Methylphenidate ER (long-acting) 10mg capsules. The contract is a Firm Fixed Price Delivery Order with a performance period ending on May 9, 2025.

AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical supplier of medical and pharmaceutical products to federal agencies, including the Defense Health Agency, U.S. Coast Guard, and other government entities. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This delivery order is not set aside and represents open competition.

Generated 8/10/25, 1:22 AM